Sherbrooke Park Advisers LLC Care Dx, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 25,800 shares of CDNA stock, worth $466,722. This represents 0.18% of its overall portfolio holdings.
Number of Shares
25,800
Previous 7,915
225.96%
Holding current value
$466,722
Previous $247 Million
123.5%
% of portfolio
0.18%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$95.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$87.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$48.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$43.6 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$39.9 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $967M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...